Transaction in Own Shares - Replacement
Source: RNS
Replacement Transactions in own shares
The following amendment(s) has (have) been made to the 'Petershill Partners plc - RNS - 04.11.22' announcement released on 7 November 2022 at 07:00 under RNS No 4418F.
The number and cost of shares the Company has purchased since 9 May 2022 and current number of ordinary shares in issue.
All other details remain unchanged.
The full amended text is shown below.
Petershill Partners plc (the Company) announces today it has purchased the following number of its ordinary shares of USD$0.01 each through J.P. Morgan Securities plc.
|
Date of purchase: |
4 November 2022 |
|
Aggregate number of ordinary shares purchased: |
636,361 |
|
Lowest price paid per share: |
198.2000 |
|
Highest price paid per share: |
202.0000 |
|
Average price paid per share: |
199.9902 |
The Company intends to cancel the purchased shares.
Since 9 May 2022, the Company has purchased 19,882,394 shares at a cost (including dealing and associated costs) of £40,434,136.71.
Following the above transaction, the Company holds none of its ordinary shares in treasury and has 1,136,813,635 ordinary shares in issue (excluding treasury shares).
The table below contains detailed information about the purchases made as part of the buyback programme.
Schedule of Purchases
|
Shares purchased: |
(ISIN: GB00BL9ZF303) |
|
Date of purchases: |
4 November 2022 |
|
Investment Firm: |
J.P. Morgan Securities plc |
Aggregate information:
|
Venue |
Volume-weighted average price |
Aggregated volume |
Lowest price per share |
Highest price per share |
|
London Stock Exchange |
200.0251 |
348,024 |
198.2000 |
202.0000 |
|
CHI-X Europe |
199.9789 |
46,586 |
198.2000 |
201.5000 |
|
Turquoise |
199.7865 |
41,144 |
198.4000 |
202.0000 |
|
BATS Europe |
199.9680 |
178,314 |
198.2000 |
202.0000 |
|
Aquis |
200.0247 |
22,293 |
198.2000 |
202.0000 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
